OrthoPediatrics Corp.
DE ˙ DB ˙ US68752L1008
15,50 € ↑1,50 (10,71%)
2026-06-05
AKTIENPREIS
SecurityDE:2X7 / OrthoPediatrics Corp.
InstitutionState Street Corp
Latest Disclosed Ownership414,041 shares
Latest Disclosed Value $ 6,570,831
State Street Corp reports 4.71% increase in ownership of 2X7 / OrthoPediatrics Corp.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 414,041 shares of OrthoPediatrics Corp. (DE:2X7) valued at $5,382,533 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 395,410 shares of OrthoPediatrics Corp.. This represents a change in shares of 4.71% during the quarter. The current value of the position is $6,417,636 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ORTHOPEDIATRICS COM 68752L100 414,041 18,631 4.71 6,571 -6.44 0.0002
2026-02-13 2025-12-31 13F ORTHOPEDIATRICS COM 68752L100 395,410 -31,774 -7.44 7,022 -11.28 0.0002
2025-11-14 2025-09-30 13F ORTHOPEDIATRICS COM 68752L100 427,184 -1,234 -0.29 7,916 -13.99 0.0003
2025-08-14 2025-06-30 13F ORTHOPEDIATRICS COM 68752L100 428,418 -16,990 -3.81 9,202 -16.12 0.0003
2025-05-15 2025-03-31 13F ORTHOPEDIATRICS COM 68752L100 445,408 1,460 0.33 10,970 6.61 0.0005
2025-02-14 2024-12-31 13F ORTHOPEDIATRICS COM 68752L100 443,948 26,050 6.23 10,291 -9.17 0.0004
2024-11-14 2024-09-30 13F ORTHOPEDIATRICS COM 68752L100 417,898 4,236 1.02 11,329 -4.77 0.0005
2024-08-14 2024-06-30 13F ORTHOPEDIATRICS COM 68752L100 413,662 -20,157 -4.65 11,897 -5.96 0.0005
2024-05-15 2024-03-31 13F ORTHOPEDIATRICS COM 68752L100 433,819 13,719 3.27 12,650 -7.37 0.0006
2024-02-14 2023-12-31 13F ORTHOPEDIATRICS COM 68752L100 420,100 27,768 7.08 13,657 8.79 0.0007
2023-11-14 2023-09-30 13F ORTHOPEDIATRICS COM 68752L100 392,332 -30,714 -7.26 12,555 -32.32 0.0007
2023-08-14 2023-06-30 13F ORTHOPEDIATRICS COM 68752L100 423,046 3,419 0.81 18,551 -0.19 0.0010
2023-05-15 2023-03-31 13F ORTHOPEDIATRICS COM 68752L100 419,627 44,354 11.82 18,585 24.66 0.0010
2023-05-15 2022-12-31 13F/A-99 ORTHOPEDIATRICS COM 68752L100 375,273 15,426 4.29 14,910 -10.20 0.0009
2023-05-15 2022-12-31 13F ORTHOPEDIATRICS COM 68752L100 375,273 15,426 14,910 0.0009
2022-11-15 2022-09-30 13F ORTHOPEDIATRICS COM 68752L100 359,847 -18,963 -5.01 16,603 1.57 0.0011
2022-08-15 2022-06-30 13F ORTHOPEDIATRICS COM 68752L100 378,810 20,340 5.67 16,346 -15.54 0.0010
2022-05-16 2022-03-31 13F ORTHOPEDIATRICS COM 68752L100 358,470 -13,288 -3.57 19,354 -13.03 0.0010
2022-02-14 2021-12-31 13F ORTHOPEDIATRICS COM 68752L100 371,758 -10,496 -2.75 22,253 -11.13 0.0011
2021-11-15 2021-09-30 13F ORTHOPEDIATRICS COM 68752L100 382,254 -37,767 -8.99 25,041 -5.64 0.0013
2021-08-16 2021-06-30 13F ORTHOPEDIATRICS COM 68752L100 420,021 -19,546 -4.45 26,537 23.84 0.0014
2021-07-09 2021-03-31 13F/A-1 ORTHOPEDIATRICS COM 68752L100 439,567 12,645 2.96 21,429 21.68 0.0012
2021-05-17 2021-03-31 13F ORTHOPEDIATRICS COM 68752L100 439,567 12,645 21,429 0.0012
2021-02-16 2020-12-31 13F ORTHOPEDIATRICS COM 68752L100 426,922 62,861 17.27 17,611 5.34 0.0011
2020-11-10 2020-09-30 13F ORTHOPEDIATRICS COM 68752L100 364,061 54,617 17.65 16,718 23.46 0.0011
2020-08-14 2020-06-30 13F ORTHOPEDIATRICS COM 68752L100 309,444 121,142 64.33 13,541 81.42 0.0010
2020-06-19 2020-03-31 13F/A-1 ORTHOPEDIATRICS COM 68752L100 188,302 19,763 11.73 7,464 -5.76 0.0007
2020-05-11 2020-03-31 13F ORTHOPEDIATRICS COM 68752L100 188,302 19,763 7,464 655.4895
2020-02-06 2019-12-31 13F ORTHOPEDIATRICS COM 68752L100 168,539 7,481 4.64 7,920 39.46 0.0005
2019-11-14 2019-09-30 13F ORTHOPEDIATRICS COM 68752L100 161,058 -3,631 -2.20 5,679 -11.58 0.0004
2019-08-14 2019-06-30 13F ORTHOPEDIATRICS COM 68752L100 164,689 38,804 30.82 6,423 15.36 0.0005
2019-05-15 2019-03-31 13F ORTHOPEDIATRICS COM 68752L100 125,885 15,023 13.55 5,568 43.99 0.0004
2019-02-12 2018-12-31 13F ORTHOPEDIATRICS COM 68752L100 110,862 11,162 11.20 3,867 5.80 0.0004
2018-11-09 2018-09-30 13F ORTHOPEDIATRICS Common equity shares 68752L100 99,700 26,129 35.52 3,655 86.38 0.0003
2018-08-14 2018-06-30 13F ORTHOPEDIATRICS Common equity shares 68752L100 73,571 42,458 136.46 1,961 318.12 0.0002
2018-05-15 2018-03-31 13F ORTHOPEDIATRICS Common equity shares 68752L100 31,113 18,605 148.74 469 95.42 0.0000
2018-02-14 2017-12-31 13F ORTHOPEDIATRICS Common equity shares 68752L100 12,508 12,508 240 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.